NCT02454842 · Interventional trial
Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients
Overall registry status Terminated
Phase 2
Conditions NSCLC, Non-small Cell Lung Cancer, Non-squamous NSCLC
Delaware Valley sites
- University of Pennsylvania-Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory